KoBioLabs

KoBioLabs Net Debt/Equity

The Net Debt to Equity Ratio of KoBioLabs (348150.KQ) as of Nov 16, 2026 is 0.20. In the previous year, Net Debt to Equity Ratio was -1.14 — a change of -117.45% (higher).

Net Debt/Equity

0.20

YoY

-117.45%

Last updated:

Net Debt to Equity Ratio of KoBioLabs is 2025 0.20 . Net Debt to Equity Ratio of KoBioLabs was 2024 -1.14 . It decreases by -117.45% higher compared to the previous year.

The KoBioLabs Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2018
0.70 KRW
Jan 1, 2019
0.61 KRW
Jan 1, 2020
-0.92 KRW
Jan 1, 2021
-0.87 KRW
Jan 1, 2022
-1.05 KRW
Jan 1, 2023
-1.26 KRW
Jan 1, 2024
-1.14 KRW
Jan 1, 2025
0.20 KRW
The KoBioLabs Net Debt/Equity history
YEARNet Debt/EquityYoY
0.20-117.45%
-1.14-10.02%
-1.26+20.74%
-1.05+19.95%
-0.87-5.10%
-0.92-250.07%
0.61-12.50%
0.70—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Net Debt to Equity Ratio of KoBioLabs is 0.20 in 2025.

Net Debt to Equity Ratio of KoBioLabs changed from -1.14 to 0.20, representing a -117.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's KoBioLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — KoBioLabs

All Key Metrics — KoBioLabs